http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#head http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#assertion http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#provenance http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#publicationInfo http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#assertion http://bio2rdf.org/drugbank:DB01235 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01235_DB01267 http://bio2rdf.org/drugbank:DB01267 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01235_DB01267 http://bio2rdf.org/drugbank_resource:DB01235_DB01267 http://purl.org/dc/terms/identifier drugbank_resource:DB01235_DB01267 http://bio2rdf.org/drugbank_resource:DB01235_DB01267 http://purl.org/dc/terms/title DDI between L-DOPA and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, levodopa. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary. http://bio2rdf.org/drugbank_resource:DB01235_DB01267 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB01235_DB01267 http://www.w3.org/2000/01/rdf-schema#label DDI between L-DOPA and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, levodopa. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary. [drugbank_resource:DB01235_DB01267] http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#provenance http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#publicationInfo http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#signature.MCwCFC7tdS-2_mgf http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#signature.MCwCFC7tdS-2_mgf http://purl.org/nanopub/x/hasSignature MCwCFC7tdS+2/mgfotx8o8QD2hecd7WsAhQLUTw9I0DtV5EICy+JjuT7OgR5uA== http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#signature.MCwCFC7tdS-2_mgf http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk http://purl.org/dc/terms/created 2018-03-30T11:12:28.981+02:00 http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk#signature.MCwCFC7tdS-2_mgf http://bio2rdf.org/drugbank_resource:DB01235_DB01267_nanopub.RAfnSl76_c3Y8eyfgQ8sWhQBbNAV8VGom6Jky1DLpdqvk http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234